Beijing Wandong Medical TechnologyLtd Full Year 2024 Earnings: EPS: CN¥0.22 (vs CN¥0.27 in FY 2023)

Beijing Wandong Medical TechnologyLtd (SHSE:600055) Full Year 2024 Results

Key Financial Results

• Revenue: CN¥1.52b (up 23% from FY 2023).
• Net income: CN¥157.4m (down 17% from FY 2023).
• Profit margin: 10% (down from 15% in FY 2023). The decrease in margin was driven by higher expenses.
• EPS: CN¥0.22 (down from CN¥0.27 in FY 2023).

The end of cancer? These 15 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Beijing Wandong Medical TechnologyLtd shares are down 3.2% from a week ago.

Risk Analysis

Before you take the next step you should know about the 3 warning signs for Beijing Wandong Medical TechnologyLtd (1 doesn't sit too well with us!) that we have uncovered.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.